A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Sanofi's $1.6B acquisition ...

Overview of Companion Diagnostics MarketThe Companion Diagnostics Market is evolving rapidly, driven by the growing demand ...

Beyond the Sandwich Generation, Connecting the Digital Dots reveals how teens and older adults are navigating screen time, ...

Complete Response Letters recently issued by the FDA signal heightened scrutiny of trial design and reinforce the agency’s shifting regulatory expectations for sponsors and CROs.

For more, check out Google's plans for smart glasses with AndroidXR.

MSL Group Middle East's Aimée Ramos says that the bartering model isn’t broken, but it's dangerously misunderstood in ...

Transportation and Infrastructure Committee leaders have introduced legislation in the U.S. House that could provide the most robust legislative reform of the Federal Emergency Management Agency (FEMA ...

Greetings, and welcome to the Five Point Holdings Second Quarter 2025 Conference Call. As a reminder, this call is being recorded. Today's call may include forward-looking statements regarding Five ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion under accelerated ...

CET1 capital ratio as of June 30, 2025 is a preliminary estimate. *Non-GAAP Financial Measure. "Our second quarter results underscore the strength of our franchise and a leading market position in the ...